The hallmark of PBC is the presence of anti-mitochondrial antibodies (AMA) in the serum of 90–95% of patients [2,3], targeting the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2). This evidence concerns the gene DLAT and primary biliary cholangitis.